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Abstract 
One of the greatest puzzles in wound healing is how to substitute or replace the defect caused 
by loss and damaged tissue or organs. In regenerative medicine, Tissue Engineering has been 
proposed to supply this demand by generating tissues in vitro. Bioreactors are the key to 
translate these cells and tissue-based constructs into large-scale biological products that are 
clinically effective, safe and financially pliable. In this review, we summarise the different up-
to-date bioreactor designs being used for different cell types and special design scaffolds, and 
highlight advantages of different bioreactors, current challenges and the future trends. It is our 
belief that with efforts combined from multiple disciplinary participants, a novel bioreactor 
system that is capable of fast, large scale tissue culture would come about in near future. 
 
Abbreviations 
AAA: Abdominal Aorta Aneurysm 
ASC: Adipose Stem Cells 
ALP: Alkaline Phosphatise 
BMSC : Bone Marrow Stem Cells 
DNA: Deoxyribonucleic Acid 
DO: Dissolved Oxygen 
EC: Endothelial Cell 
ECM: Extra-Cellular Matrix 
EPC: Endothelium Progenitor Cell 
EpSC: Epidermal Stem Cell 
ESS: Engineered Skin Substitute 
FEP : Fluorinated Ethylene Propylene 
GAG : Glycosaminogylcan 
HP: Hydrostatic Pressure 
MDP: Markov Decision Process 
mRNA: Messenger Ribonucleic Acid 
MSC: Mesenchymal Stem  
NASA: National Aeronautics and Space Administration 
PCR: Polymerase Chain Reaction 
PGA: Polyglycolic Acid 
PLGA: Poly Lactic-Glycolic Acid 
PMMA: Polymethlmethacrylate 
POSS-PCU: Polyhedral Oligomeric Silsesquioxane Poly (caprolactone-urea) Urethane 
PTFE: Polytetrafluoroethylene 
PU: Polyurethane 
RCCS: Rotating Cell Culture System 
SEM: Scanning Electron Microscope 
SMC: Smooth Muscle Cell 
STSG: Split Thickness Skin Graft 
TE: Tissue Engineering 
TEHV: Tissue Engineered Heart Valve 
VTE: Vascular Tissue Engineering 
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1. Introduction 
The loss and damage of organs cause a huge social and economic burden. With a limited 
capacity for self-repair and surgeon-dependent techniques, restoration of the original form and 
structure are impossible, and new methods for organ regeneration are required [1]. Currently, 
implantable medical devices are being used to substitute a number of damaged tissues and 
organs. For instance, hip and knee replacements have been utilised for a number of years, yet 
still have a time-span limitation and possible implant failure due to poor bone infiltration. 
These commercially available products also fall short of the requirements for active 
individuals. Articular cartilages are often damaged from degenerative joint diseases and 
congenital abnormalities, for which there are no suitable substitutes for surgical reconstruction. 
Surgeons currently restore peripheral nerve injuries using autologous tissue, however there are 
limitations in harvesting adequate substitutes depending on the amount required by the 
autoplastic technique for restoration. Overall, there is a large demand for providing a medical 
alternative to restore severely damaged tissues when required [2]. One way to meet this 
demand has been proposed by TE via generating tissues in vitro. One of the aims of TE is to 
develop viable substitutes to restore, maintain or improve tissue function in vivo using materials 
capable of mimicking natural ECM. The major challenge is to translate these cells and tissue-
based constructs into large-scale biological products that are clinically effective, safe and 
financially plausible [3].  
Bioreactors have played a vital role in TE as they are capable of cultivating mammalian 
cells under a controlled environment up to an industrial scale [3]. Several operational 
conditions can be modified and controlled including pH, temperature, oxygen tension and 
perfusion of the cells as well as external stimuli such as mechanical forces etc. [4]. Bioreactors 
can be used to aid in the in vitro development of new tissues. They provide the biochemical and 
physical regulatory signals required for cells to proliferate, differentiate and to produce ECM 
[5]. For example in vivo cells will respond to mechanical stimulation which bioreactors can 
provide, aiding cells to produce ECM within shorter a time-span under the optimal mechanical 
stiffness for the construct [6]. Mechanical stimulation has also been shown to encourage stem 
cells down different lineages, enabling different cell types to be obtained [5].
 
   
The designs of bioreactors are both tissue and application specific. Several common 
principles can be employed when designing bioreactors. First of all, they should be quick and 
easily assembled and efficient in tissue forming in a short time span and most importantly keep 
products sterile. Secondly, the materials being used to create these bioreactors must be non-
toxic to most or specific tissue types. This has ruled out most metals as they have the potential 
of releasing ions into the media which could be highly toxic to cells in most cases. The 
bioreactors must also capable of being sterilised if they are to be used again. Furthermore 
sensors need to be built into them for accurately monitoring culturing conditions [7]. At least, 
the pumps must be accurate in creating mechanical stimuli to the smallest degree as most cells 
will respond to extremely small forces [8].  
Besides the aforementioned conventional bioreactors, there are also in vivo bioreactors. 
The principle of an in vivo bioreactor is to implant a well-designed TE scaffold with or without 
cell seeding onto a well vascularized site of a living organism and harvest when matured. There 
are two vectors of choice, xenogenic or autogenic [9]. Liu et al in 2014 implanted growth 
factors loaded scaffolds onto the latissimus dorsi muscles of pigs and successfully induced in-
situ MSCs to differentiate into osteoblasts and generated well vascularized bone tissue products 
[10]. Kokemueller et al in 2010 implanted a β-tricalcium phosphate scaffold loaded with 
morcellized autologous bone graft from the iliac crest to the latissimus dorsi of a patient 
suffered from chronic mandibular osteomyelitis requiring resection. After 6 months, a well 
vascularized construct was harvested and used for reconstructing his mandible, and at 12 
months of following up the reconstructed mandible was still viable [11]. The future trends of in 
 5 
 
vivo bioreactors lie with implantable devices which are able to monitor and control the in vivo 
culturing condition and scaffolds with higher biocompatibility that is suitable for long term 
implantation with minimal rejections [12]. This type of bioreactor does not fit the focus of 
bioreactors that are suitable for large industrial scale TE constructs, and have been mentioned 
to provide context and will be explored no further in this paper. 
This review aims to provide a concise discussion of the different types of bioreactors used 
for generating cartilage, bone, vascular tissue, skin and nerve. We will highlight the success in 
engineering tissues using bioreactors, describing novel designs and explain the future work that 
is required to expand the use of bioreactors in regenerative medicine.  
2. Bioreactors for Cartilage Tissue Expansion 
Upon the natural development of human cartilage, forces are constantly applied on them 
during movements of the body joints. It is been well documented that mechanic forces 
promotes proliferation and differentiation of chrondrocytes [2]. For the very same reason, the 
key principle for cartilage bioreactors is to mimic the in vivo mechanical loading [13]. There 
are different types of bioreactors systems designed to induce shear stress, perfusion, HP and 
compression for stimulating cartilage formation.  
2.1. Bioreactors for Inducing Shear Force 
Bioreactors for inducing shear force have been used widely for cartilage tissue engineering 
for decades. They are commonly made up of rotating vessels, spinner flasks and stirred double 
chambers. Human cartilage progenitor cells have shown to differentiate into mature 
chrondrocytes on a hydroxyapatite, collagen and chondroitin sulfate scaffold after 6 weeks 
using a rotating wall vessel bioreactor with chondrogenic induction media [3]. BMSCs have 
also been shown to differentiate into chrondrocytes after 3 weeks of culture in rotating 
bioreactors [2]. Marlovits et al showed that with the rotating bioreactor, large cylindrical 
cartilaginous tissues can be formed in dimensions of 1.25 ± 0.06 X 0.60 ± 0.08 cm, with 
confirmed mRNA expression of aggrecan, collagen type I and II, GAG/DNA ratio within 12 
weeks [14]. To improve the design of rotating vessels Chang et al formulated a double chamber 
bioreactor that is capable of forming biphasic osteochondral grafts in a single apparatus (Figure 
1A). This device consists of two tubular glass chambers with a magnetic bar stirrer separated 
by a silicon rubber septum with holes, attached to a tube coated with biphasic composite 
scaffolds. The scaffolds were coated with gelatin before 10 million porcine chrondrocytes were 
injected, the graft can be harvested after cultivating for 4 weeks [15]. 
Spinner flasks bioreactors have also been showed high efficiency in cartilage regeneration 
confirmed by PCR and histological observation [4], they have also been proven to support in 
vitro chrondrogenic differentiation of ASCs, attributed to the formation of a spheroid culture 
allowing for cell-cell interactions [4]. Rabbit MSCs have also showed to macroaggregate on a 
PLGA scaffold after being cultivated in 4 weeks in spinner flasks in the hope of making trachea 
grafts [5].  
2.2. Bioreactors for Inducing Perfusion 
Bioreactors applying perfusion have also shown to be extremely successful for cartilage 
tissue formation. Cylindrical shaped glass vessels filled with culture medium are generally used 
for this application. (Figure 1B) Perfusion bioreactors have found to be increasing cartilage 
quality as they improve ECM retention. For instance, increasing flow rates of 0.075–0.2 mL 
min
-1 
to human chrondrocytes seeded on PLGA scaffolds for up to 5 weeks increased the 
percentage of GAG retained in the ECM [7]. Furthermore, cartilage cultivated on perfusion 
bioreactors was found to be viable and homogeneously cartilaginous, with biomechanical 
properties resembling most of native cartilage [8]. Most perfusion bioreactors are 
unidirectional, the culture medium is perfused from a medium reservoir then throughout the 
cylindrical bioreactor. Wendt et al illustrated a bi-directional bioreactor which was more 
effective than spinner flasks and static seeding of chrondrocytes (Figure 1C) [16]. Scaffolds 
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were placed in polysulfone/Teflon chambers and positioned at the bottoms of two glass 
columns and connected through a U-shaped glass tube at their base. Flow of cell suspension 
was induced with the use of a vacuum pump whilst the flow rate regulated by a flow meter. The 
direction of flow reversed when the cell suspension reached the level of the sensors placed near 
the top of each glass column. Perfusion seeding of chondrocytes into poly-active foams using 
the perfusion system resulted in “viable cell seeding efficiencies,” defined as the percentages of 
initially loaded cells that were seeded and remained viable. It was significantly higher (75 ± 
6%) than those by static (57% ± 5%) and spinner flask seeding (55% ± 8%) [16]. 
2.3. Bioreactors for Inducing Hydrostatic Pressure 
Bioreactors that induce HP also showed to have significantly enhanced cartilage 
formation. HP can be applied to a monolayer of cells seeded on a petri-dish by covering them 
with culture medium and placing them in a pressure chamber where a gas phase acts on both 
sides of the dish. HP bioreactors consist of fluid filled chambers attached to a water pump. The 
vessel is completely filled with water and a syringe sealed at the top. The syringe contains the 
culture volume with the sample. The water pump compresses the water inside the vessel, 
resulting in syringe moving and transmitting HP to the culture volume. The optimal magnitude, 
frequency, and duration of application of HP have not been identified yet. It was suggested that 
dynamic HP has a beneficial effect on chrondrocytes grew in a monolayer compared with static 
HP [17]. Interestingly, recent studies found static HP to be more efficient on chondrocytes in 
3D culture. This is further verified in Toyoda’s study as immature bovine chondrocytes on 3D 
collagen sponges exposed to static HP at 2.8MPa for up to 15 days showed greater GAG 
production at 5 and 15 days of culture [18]. On the other hand, dynamic HP loading of 
chrondrocytes in 3D culture yielded better tissue formation over time and the possibility of 
promoting differention. Correia et al illustrated that application of 0.4 MPa pulsatile HP on 
human nasal chrondrocytes for 3 weeks encapsulated in gellan gum hydrogels encouraged 
enhanced tissue formation compared to continuous 0.4 MPa HP and static loading [19].
 
Candiani et al applied 10 MPa HP at the frequency of 0.33 Hz for 4 hours/day resulted in 
enhanced differentiation of bovine chrondrocytes toward a mature chondrocytic phenotype on 
synthetic 3D porous scaffolds (DegraPol) [20]. 
2.4. Bioreactors for Inducing Compression 
Compression bioreactors are becoming more widely used in cartilage tissue engineering 
nowadays. They apply dynamic compression loading which is similar to the natural 
physiological loading of cartilage. Compression bioreactors can improve mass formation and 
increase the elastic modules of the cartilage formed to approach that of native cartilage [21, 
22]. Mauck et al in 2000 seeded cells on agarose disks in dynamic compressions with a peak-
to-peak compressive strain amplitude of 10% at a frequency of 1 Hz, 3 times (1 hour on, 1 hour 
off)/day, 5 days per week for 4 weeks resulted in a six-fold increase in the equilibrium 
aggregate modulus over free swelling controls after 28 days of loading (100 ± 16 kPa versus 15 
± 8 kPa, p < 0.0001). Sulfated GAG content and hydroxyproline content was also found to be 
greater in dynamically loaded disks compared to free swelling controls at day 21 (p < 0.0001 
and p = 0.002, respectively) [23].
  
2.5. Bioreactors for Inducing Combined Mechanical Force 
Bioreactors applying combined mechanical force are being developed. Shahin et al 
illustrated that human chrondrocytes benefit from combined application of intermittent 
unconfined shear and compressive loading at a frequency of 0.05 Hz using a peak-to-peak 
compressive strain amplitude of 2.2% superimposed on a static axial compressive strain of 
6.5% for 2.5 weeks. GAG and collagen type II productions were enhanced between 5.3- and 
10-fold after simultaneous stimulation [8]. We foresee that future research would be centered in 
a more complex mechanic system that mimics the in vivo mechanical loading condition of 
natural cartilage. 
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3. Bioreactors for Bone Tissue Expansion 
Bioreactors for bone are similar to the ones for cartilage. In TE studies, one of bone’s 
characteristics resembles vascular tissue in as much as it allows the perfusions of nutrients and 
oxygen. In vivo, loadings that are applied to bone cause fluid to flow through the bone, while 
shear stress influence osteoblasts and osteocytes to differentiate and mineralize [24]. Therefore 
in bioreactors designed for bone formation, shear stress and perfusion are constantly 
highlighted.  
Much like bioreactors for cartilage, spinner flasks are used to induce shear force. Research 
suggests that their use enhance both early osteoblastic marker ALP and late osteoblastic 
markers osteocalcin. Mygind et al in 2007 cultured human MSCs on a coralline porous scaffold 
presenting with enhanced proliferation and differentiation on spinner flasks than static controls 
[25]. Stiehler et al in 2008 repeated the experiment on PLGA scaffolds for up to 3 weeks and 
demonstrated a 20% increase in DNA content (21 days), enhanced ALP specific activity (7 
days and 21 days), a more than tenfold higher Ca
2+
 content (21 days), and significantly 
increased transcript levels of early osteogenesis markers (e.g., COL1A1, BMP2, RUNX-2) as 
compared with static culture [26].  
Rotating wall vessel bioreactors are also commonly used in bone TE. TE constructs from 
these type of bioreactors have demonstrated enhanced osteoblast cell phenotypic expression 
and mineralized matrix synthesis comparing with static conditioning bioreactors [27]. It 
provided better-controlled oxygen supply, caused fewer turbulence while inducing shear stress 
in comparison to spinner flasks [28]. Song et al in 2007 demonstrated that rat osteoblasts 
cultured on rotating wall vessel biorectors expanded by more than ten times than spinner flasks 
and static controls, and they presented better morphology, viability and stronger ability to form 
bone tissue [29]. Concerns had been raised on the collision of scaffolds with the walls of the 
rotating vessel chamber as the scaffolds were usually denser than the medium [30]. However, 
several groups succeeded in developing scaffolds with densities lower than water. Studies with 
these scaffolds in a rotating wall vessel bioreactor showed greater expression of ALP and 
calcium deoposition in osteoblasts compared to static controls [31]. 
Another type of bioreactor being used in bone TE is the perfusion bioreactor. They are 
able to effectively pump media directly through the scaffold subsequently allowing a better 
exchange of oxygen and nutrients. This is useful in large tissue mass constructs as it allows for 
more precise control of the culturing environment.
 
Bancroft et al described a commonly used 
perfusion bioreactor system as shown in Figure 1B. The result showed that mineralized matrix 
production dramatically increased when compared to statically cultured constructs. The total 
calcium content of the cultured scaffolds were also elevated as flow rate increased [32].
 
Flow 
rate is one of the most essential parameters for bone TE. The optimal range varies according to 
the design of the bioreactor and the cell type used. Grayson et al illustrated in a novel 
bioreactor design that osteoblasts proliferation and mineral content of the final construct were 
significantly increased as flow rate increased within the range of 0.3~3ml/min [33]. In addition 
to flow rate, further development was made to optimize perfusion bioreactors for bone tissue in 
the hope of finding a more cost effective and less complex alternative. For instance, scaffolds 
with a central channel can enhance bone formation [34]. Jansen et al showed that with a central 
channel perfused -tricalcium phosphate scaffold, the proliferation of MSCs seeded was 
enhanced and osteoblast differentiation was observed after 19 days [35]. Frohlich et al in 2010 
cultured ASCs in a similar bioreactor system resulting in formation of compact and viable bone 
tissue after 5 weeks [36]. It is clear that perfusion bioreactors promote osteogenic 
differentiation and bone formation [37].  
4. Bioreactors for Vascular Tissue 
The incidence of peripheral vascular diseases is gradually increasing in both developed 
and undeveloped countries. The primary treatment strategy for peripheral vascular diseases is 
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surgical bypass operations. However, due to the shortage of usable vessels, suitable vascular 
substitutes are in great demand [38, 39]. Currently, there are two major trends in developing 
vascular substitute. One is looking at new synthetic biomaterial such as Dacron and PTFE. 
They are the only commercially used materials in the development of cardiovascular implants. 
Dacron is used mostly in large diameter bypass graft such as AAA etc. and PTFE is used in 
other bypass grafts with diameters over 6 mm. When comes to bypass grafts with a smaller 
diameter however, neither show an ideal biocompatibility and patency, that is to say that the 
patency of PTFE bypass grafts for lower limbs are only 25% in 5 years [40]. These materials 
are over 25 years old and still being used currently for cardiovascular implants, and still do not 
meet all clinical needs [41]. Alternatively, VTE aims to construct vascular bypass using ECs 
and SMCs with a biodegradable or non-biodegradable scaffold [42]. 
4.1. Bioreactors for Vascular Bypass Grafts  
Bioreactors that could closely monitor and control physical, biochemical and mechanical 
conditions are essential for VTE [43].
 
There are four major components in a vascular bioreactor 
which are: culturing chambers, motor-driven pumps, medium reservoirs and a temperature 
controller. All components are assembled into a double-enclosure circuit loop. The culturing 
circuit consists of two separated circulating loop: an incubating loop and a medium-
replenishing loop. With the incubating loop, the pump gives a pulsatile flow which drives the 
culturing medium to supply oxygen and nutrients. In the medium-replenishing loop, a one-
direction pump (not necessarily pulsatile load) drives fresh medium into the incubating 
chamber and old medium into the gas/liquid and liquid/liquid exchanger to replenish oxgyen, 
nutrients and to remove waste products (Figure 2) [44].
 
Song et al reported an integrated 
vascular bioreactor system which added a PH sensor, a buffer-driven PH controller, a DO 
sensor, a pump-driven DO controller, an ozonizer, a position detector and a force monitor on 
the basic layout. The system was designed for complete computer-control to maintain a stasis-
balanced condition and to mimic in vitro, the physiological mechanical stimulation and fluid 
flow effect that presented in arteries in vivo. Engineered bypass grafts were put into the 
computer-controlled integrated vascular bioreactor system that could provide a dynamic stasis 
conditioning and a static conditioned bioreactor for a two-week culture. Results showed that the 
proliferation rate of cells in dynamic conditioning was significantly higher than the one in static 
conditioning [44]. 
Another group of researchers are looking at MDP in developing the next generation of 
VTE bioreactors. MDP is a system designed to find out the growth model in any VTE 
bioreactors using symbolic regression [45]. Symbolic regression is a method based on 
evolutionary computation and genetic programming [46].
 
It is designed for the purpose of 
searching mathematical expressions and minimizing possible error matrices. With MDP, a 
mathematical framework is generated for optimizing problems under stochastic environment 
and forecasting successive action interference [47].
 
It performs calculations to explore whether 
the system is likely to work prior to assembly.  It can also be used to explore the combination 
of optimal parameters for greatest efficiency such as optimal flow rate, oxygen in-flow, 
nutrients top up frequency etc.  While the MDP system being used to exploit models in VTE 
bioreactors is still theoretical, it is likely to be a future trend.  
Different cell sources could result differently even under the same VTE bioreactor system. 
ECs and SMCs are the conventional choices of cell sources for VTE. Lei Song et al 
successfully developed a small-diameter vascular construct with exact histological mimicking 
of natural artery using rat aortic SMCs and ECs on the external and internal surface of a de-
cellularised rabbit aorta scaffold in a similar structured pulsatile pump bioreactor system [44]. 
Various stem cells are also being investigated as cell sources in VTE such as ASCs, MSCs and 
EPCs [48].
 
Recent research has suggested adding EPCs into the incubating loop along with a 
surface functionalised scaffold that process EPC-capturing feature resulted in EPCs 
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immobilization onto the scaffold’s inner surface and differentiate into monolayer of EC 
coverage [49, 50]. 
4.2. Bioreactors for Stents 
In addition to bypass grafts, VTE bioreactors are increasingly used as stent testing and 
evaluating platforms for their biocompatibility, thrombogenicity and ability of in-situ 
endothelialization in vitro. ECs or EPCs are usually added into the incubating loop to test the 
cell capturing efficiency of the tested stent. Stent bioreactors resemble the design of VTE 
bioreactors, with the outer medium-replenishing loop absent and with a roller pump instead of a 
pulsatile one [51]. Weinandy et al used a stent bioreactor system to test the endothelialization 
of BioStent (a nitinol stent covered with fibrin gel) with ECs added into the loop resulting is 
successful cell anchoring, growth and generation of ECMs in-situ (Figure 3)  [52].  
4.3. Bioreactors for Heart Valves 
TEHVs is a potential route to substitute for heart valve prostheses that are essential for 
treating valvular diseases [53]. To create TEHVs in vitro requires yet another integrated 
bioreactor system. The general layout of the TEHV bioreactors includes only two major 
components, a motor-driven pulsatile pump and an incubating chamber. The incubating 
chamber is designed to have two separated compartments isolated by a septum. In the middle of 
the septum is the position for the fixation of the TEHV scaffold, on the side are one-direction 
valves that open opposite to the opening of TEHV (Figure 4). When the pulsatile pump starts 
working, it drives the culture medium to burst through the TEHV into the distal compartment.  
This also pushes the culture medium in the outer compartment to flow through those one-
direction valves back to the proximal compartment, thus forming an intra-chamber, inter-
compartmental flow circuit [54, 55]. 
Driven by insufficient supply of vascular bypass and heart valve substitutes and the high 
up in demand, VTE bioreactors are progressing swiftly in smart culturing. By combining 
research models with mathematical frameworks, we now have the means to select and isolate 
optimal parameters that achieve the best results. Based on literature, we believe that the next 
generation of bioreactors for vascular tissue will be an integrate system which have “smart” 
control over multiple parameters in the manner of “monitoring-feedback-control”. It is also our 
belief that in the absence of ideal testing models and while the financial and ethical cost of 
using animal as testing subjects are growing, the role of VTE bioreactor be used as a testing 
and evaluating in vitro tool will become prominent in the near future [56]. 
5. Bioreactors for Skin Expansion 
Skin is the largest organ of our body. It provides physical protection, prevents fluid loss, 
as well as thermal regulation, sensation and immunological functions. Loss of integrity of skin 
area is usually caused by trauma, burn and surface tumour/carcinoma. Restoration of skin is of 
essence in treating those conditions. It is also a primary treatment strategy for post-traumatic 
conditions, such as scars (especially hypertrophic scars) and regional cosmetic changes. 
However, insufficiency of donor skin supply has led a huge demand for a suitable skin 
substitute. There are already several commercial available skin substitute, such as: Integra 
(collagen based regeneration template), Oasis (cellular intestinal mucosa), Dermagraft (tissue 
engineered product) [57-61].
 
Yet there are limitations in these products like low clinical success 
rate – the success rate of Integra in large wounds is only 60% (reported by Machens, HG et al 
in 2001), many products failed commercially such as Dermagraft due to its high cost. 
5.1. The Kerator 
ESSs are epidermal substitutes of autologous keratinocytes, attaching to a dermal analogue 
with populated autologous fibroblasts. It showed great clinical efficiency in related studies [62]. 
An integrated skin bioreactor system with dynamic conditioning is required for culturing ESSs. 
The Kerator was originally designed to produce an autologous wound dressing made up of gas-
permeable FEP film containing keratinocytes [63].
 
It is a closed loop system with a “Smart” 
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computer-controlled function. It has multiple monitoring built in and allows automatic 
feedback controlling. The basic layout of the Kerator and the image of actual system are 
illustrated in (Figure 5) [64]. 
5.2. Expanding Bioreactors for skin grafts 
It is a very common procedure for surgeons to expand full skin grafts via incising patterns 
or to mesh STSGs to obtain larger segments of autoglogous skin [65]. Ladd et al in 2009 
designed a bioreactor system to apply continuous physio-mechanical stress load in culture with 
the hope of harvesting a larger area of products. It contained an actuator mounted on the tissue 
container which secures the culturing skin or scaffold, a linear motor-driven device and an 
incubator. It is programmed to uniaxially expand the fixed tissue or scaffold to 20% of its 
initial length per day, so as it will double the surface area in 5 days approximately. Human 
foreskin cultured in this system for 6 days showed a 110.7% ± 12.2% increase in surface area, 
while maintenance of cell viability proliferative potential of cells (Figure 6). 
Histomorphological and ultrastructural analyses of the expended tissue confirmed that the 
integrity of dermal structure was well preserved  [66]. 
5.3. The Rotating Cell Culture System 
The RCCS is a bioreactor system developed by the NASA with the purpose of mimicking 
microgravity condition during culture [67].
 
Study by Yuge et al suggested RCCS promotes the 
viability and proliferation of MSCs [68].
 
Lei et al cultured human EpSCs on Cytodex 3 (a 
micro-carrier) scaffold coated by collagen type IV in a RCCS (Figure 7). Results showed 
RCCS have positive effects on the differentiation and proliferation of EpSCs when compared 
with plain culturing.  It also promoted a three dimentional epidermis growth in vitro [69, 70].
 
At this point, only data on MSCs and EpSCs with RCCS is available, more cell types need to 
be tested to explore this system.  
6. Bioreactors for Nerve Tissue Expansion 
In peripheral nerve injuries, the most common repairing technique is direct end-to-end 
suturing. In the circumstance that the two nerves ends cannot be aligned tensionless, gap 
bridging with and nerve autograft materials are required. The re-innervation rate for this kind of 
procedure is 80% [71]. However, the harvest of donor graft means loss of sensory or motor 
function of the donor site and so alternative approaches of obtaining nerve graft are being 
investigated. Nervous TE is one of the prospective approaches for producing nerve graft 
substitutes [72]. Nervous tissue requires strict culturing conditions and it is even harder in 
inducing differentiation and integration. Currently, there are only few ongoing studies and even 
fewer encouraging results generated for this matter. Tao et al in 2008 designed a bioreactor 
system for nerve conduit. It consisted of a 9 cm circular tissue culturing polystyrene Petri dish, 
a peristaltic pump and a medium reservoir. All components were connected together using 
silicone tubes as shown in Figure 8. Schwann cells cultured in this bioreactor system showed 
cellular adhesion and alignment on the longitudinal axis under fluorescence microscopy [73]. 
7. Summary and Future Trends 
Bioreactors have been utilised for all aspects of TE and research in this area has brought 
us a step closer to develop numerous tissues in vitro for large-scale medical application. A 
summary of bioreactors used for a variety of different tissue types as presented in Table 1.  
In cartilage tissue engineering, mechanical stimulation is vitally important to form tissue 
that has similar elastic modulus to native tissue and for cells to produce an effective ECM [21]. 
Rotating bioreactors have shown to upregulate gene expression in osteoblasts effective for bone 
tissue engineering [74]. Perfusion bioreactors have been useful in bone engineering due to their 
capability for stimulating bone cells to increase levels of bone formation markers and 
mineralisation of the scaffold [32]. Despite these encouraging studies, there is a greater need to 
elucidate the specific biochemical and biomechanical factors need for optimal bone and 
cartilage engineering in vitro. For vascular tissue engineering, bioreactor technology is still 
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under-explored but bioreactors that provide adequate perfusion and fluid flow has shown to 
provide an optimal environment for adequate tissue formation [43]. Future work will need to 
specify the optimal cell source used to create an optimal tissue engineered vascular construct 
[75]. With the rapid expansion in skin tissue engineering, multiple bioreactors have been 
utilised for in vitro skin generation. The kerator has emerged to decrease labour costs and 
material requirements but further studies are required to understand its capability for large-scale 
production for clinical use [76, 77]. Bioreactors for nerve engineering are still in their infancy 
with few studies showing further potential for effective tissue formation in vitro. 
In this review we have summarised most of the success in tissue regeneration using 
bioreactors in recent years and highlight the progress that has been made in large-scale three-
dimensional tissue constructs or substitutes that are suitable for clinical uses. However, most 
bioreactors to date still have a low volume output, and are time consuming and labour 
extensive. They require considerable time for tissue formation and therefore still await 
optimization to meet the need of clinical practices.  
In addition to the mass-production of tissue substitutes, another future trend for bioreactor 
design would be assisting developing artificial organs that are tailored to each individuals. In 
our lab in the centre for nanotechnology in the Royal Free Campus of UCL, we have developed 
and patented a family of nanocomposite polymer namely POSS-PCU. It is an anti-
thrombogenic [78], biocompatible [79] and non-toxic [80, 81] biomaterial that is suitable to be 
used as the next generation of biomaterial for surgical implants. Our studies have also revealed 
that it is an inert biomaterial that it does not cause inflammatory reactions in the surrounding 
host tissue and show calcification resistance [82-85]. In 2011, we used this novel biomaterial 
and produced an synthetic trachea seeded with patient’s own stem cells for 36 hours before 
being implanted to replace the damaged trachea and the following-up showed implant survival 
and patient currently live without complication with the artificial trachea [86]. We have also 
developed lacrimal duct conduits and lower limb bypass grafts with this technology and are 
planning to use them in the treatments for patients. We are currently designing new generations 
of bioreactors to manufacture these artificial organs on a larger scale and faster time span to 
meet the needs of the market. 
The future success of bioreactors for TE to achieve effective replacements for clinical 
applications will depend on the collaboration between engineers, clinicians and biologists. With 
multi-disciplinary collaboration, we are soon to create a novel complex bioreactor system that 
is capable of large scale of tissue culture under short time span in vitro. 
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Figure Captions 
Figure 1. A: The double chamber bioreactor, consists of two tubular shape glass chambers, 
each containing medium with outflow and inflow and oxygen ventilation. The two chambers, 
separated by silicon rubber has multiple holes to hold the biphasic scaffold. The bioreactor 
forms two independent medium circuits. B: Flow perfusion Chamber. Each flow chamber 
contains a cassette sealed by two neoprene O-rings heed in place by a screw top. Media flow 
from top to bottom though the scaffolds. Media drawn from the first media reservoirs through 
the flow chamber and then back to the second reservoir to complete the circuit. C: Bidirectional 
bioreactor. The cell suspension oscillates between the two glass columns, flowing into the 
sample chamber containing the scaffold. The direction of the media flow reverses when it 
reaches the sensors levels. (Adapted and modified from Bancroft et al) 
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Figure 2. The schematic diagram of a vascular tissue bioreactor. The yellow circle indicates the 
incubating loop, the red circle indicates the median-replanish loop, and the blue circle indicates 
the computer-controlled integrated system. (Adapted and modified from Song et al)  
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Figure 3. Biostent after 2 weeks culture in the stent bioreactor system: A. The pre-culture 
BioStent, B and C. HE staining of PMMA section of BioStnet. (Adapted from Stefan et al)  
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Figure 4.  A pulsatile bioreactor for TEHVs with an endoscopic monitoring unit and a flow 
velocity monitoring and control system. A: Schematic diagram of the flow circulation inside 
the incubating chamber: the pulsatile pump drives the culture medium (shown in red arrow) to 
burst through the TEHV set in the middle of the septum while also pushing valve (1) is pushed 
upwards and seals the tubular connection (2) between the proximal and distal chambers. As the 
culture medium flows upwards and through the small holes, it flows downwards (shown in blue 
arrow) through the disc (3). It flows back to the proximal chamber through (2) and continue in 
the circulation. B: The over view of the pulsatile bioreactor for TEHVs. (Adapted from Konig 
et al and Aleksieva et al) 
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Figure 5. The basic layout of the Kerator and the image of actual system. Upper: A. The 
growth chamber (five-layered), B. Monitoring camera, C. Tilting acuator, D. Rocking platform, 
E. Pneumatic pinch valves. Lower: 1. Cold medium reservoir, 2. Warm medium reservoir, 3. 
Cell seeding and collection reservoir, 4. Waste product 5.Carbondioxide supply, 6. Air supply, 
7. Flow controller, 8. Humidifier bottle, 9. Carbondioxide detector, 10. Peltier cooler, 11. 
Compressed air supply. (Adapted from Balaji et al) 
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Figure 6. Skin expanding bioreactor: A. Unexpanded skin loaded in the bioreactor, B. skin in 
the bioreactor after expansion. (Adapted from Mitchell et al) 
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Figure 7. A RCCS used to culture human EpSCs. A: The RCCS in culture. B: The EpSCs and 
Cytodex 3 was loaded into the RCCS (the red round vessels), and the vessels were rotating in a 
clockwise direction. C: T over view of the RCCS. (Adapted from Antoni et al) 
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Figure 8. The bioreactor system for culturing nerve conduits: 1. 9 cm Polystyrene Petri dish, 2. 
A peristaltic pump, 3. A medium reservoir, 4. Three silicone tubes containing aligned 
microfiber scaffold inside the Petri dish (length: 40mm, diameter: 1.2mm, connected in series), 
5. Two closable inlets, 6. Two closable outlets, 7. Vent windows with an air permeable film, 8. 
Two medium inlets, 9. Two medium outlets. (Adapted from Sun et al) 
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Tables 
Table 1: Summary overview of the different bioreactors used for tissue engineering of various of tissue types. 
 
Author  
 
Year 
 
Tissue Type  
 
 
Bioreactor Characteristics 
 
Scaffold Used 
 
Cell Type Used 
 
Outcome 
 
 
 
Takebe et al  
 
 
 
Akmal et al  
 
 
 
Yoon et al  
 
 
 
Liu et al  
 
 
 
Vunjak-
Novakovic et 
al 
 
 
García et al 
 
 
Shangkai et al  
 
 
2012 
 
 
 
2006 
 
 
 
2012 
 
 
 
2010 
 
 
 
1998 
 
 
 
2012 
 
 
2007 
 
 
 
Cartilage  
 
 
 
Cartilage 
 
 
 
Cartilage 
 
 
 
Cartilage 
 
 
 
Cartilage  
 
 
 
Cartilage 
 
 
Cartilage  
 
 
 
Shear Force, Rotating 
Vessel 
 
 
Shear Force, Rotating 
Vessel 
 
 
Shear Force, Spinner Flask 
 
 
 
Shear Force, Spinner Flask 
 
 
 
Shear Force, Spinner Flask 
 
 
 
Shear Force, Stirred 
 
 
Stirred  
 
 
 
Collagen, hydroxyapatite 
and chondroitinsulfate  
 
 
2% alginate hydrogel 
 
 
 
Fibrin Gel 
 
 
 
PLGA  
 
 
 
PGA  
 
 
 
Chitosan 
 
 
Fibroin sponge 
 
 
 
Bovine and human 
articular chondrocytes   
 
 
Human cartilage 
progenitor cells 
 
 
ASCs 
 
 
 
Rabbit MSCs 
 
 
 
Chondrocytes from 
femur 
 
 
Human chondrocytes 
 
 
Chondrocytes 
 
 
 
Enhanced type II collagen 
production. 
 
 
Cells formed elastic 
cartilage-like tissue.  
 
 
Chrondrogenic 
differentiation of ASCs.  
 
 
Formation of tubular 
tracheal grafts.  
 
 
Cartilaginous tissue 
formation.  
 
 
Enhanced aggrecan and 
collagen type II production. 
 
Enhanced DNA content and 
GAG.  
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Shahin et al 
 
 
Santoro et al  
 
 
Wendt et al  
 
 
 
Mauck et al 
 
 
 
Wang et al  
 
 
 
 
 
Wang et al  
 
 
 
 
 
 
 
 
 
 
2011 
 
 
2010 
 
 
2011 
 
 
 
2000 
 
 
 
2013 
 
 
 
 
 
2009 
 
 
 
 
 
 
 
 
 
 
 
Cartilage 
 
 
Cartilage 
 
 
Cartilage 
 
 
 
Cartilage 
 
 
 
Cartilage  
 
 
 
 
 
Cartilage 
 
 
 
 
 
 
 
 
 
 
 
Perfusion  
 
 
Perfusion 
 
 
Perfusion 
 
 
 
Compression Dynamic 
 
 
 
Compression Dynamic 
 
 
 
 
 
Compression Dynamic 
 
 
 
 
 
 
 
 
 
 
 
PGA  
 
 
Hyaff-11 
 
 
Polyactive foams and 
Hyaff-11 
 
 
Agarose gel 
 
 
 
Chitosan/collagen 
 
 
 
 
 
Chitosan/collagen 
 
 
 
 
 
 
 
 
 
 
 
Human chondrocytes  
 
 
Human chondrocytes 
 
 
Human articular 
chondrocytes  
 
 
Human chondrocytes 
 
 
 
Rabbit chondrocytes 
 
 
 
 
 
Rabbit chondrocytes 
 
 
 
 
 
 
 
 
 
 
 
Enhanced ECM on scaffold. 
 
 
Form cartilage construct 
over two weeks.  
 
Bi-directional chamber 
shows enhanced cartilage 
formation.  
 
Enhanced aggregan and 
hydroproline content of 
cells on scaffolds.  
 
Rabbit chondrocytes 
showed enhanced total 
GAG deposition on the 
scaffold.  
 
 
The expression of type II 
collagen and aggrecan was 
upregulated after 3 hours of 
compression when 
compared with the free-
swelling samples of rabbit 
chondrocytes.  
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Correia et al  
 
 
 
 
Candiani et al  
 
 
 
Lammi et al  
 
 
 
 
Mizuno et al  
 
 
 
Toyoda et al 
2012 
 
 
 
 
2008 
 
 
 
1994 
 
 
 
 
2002 
 
 
 
2003 
Cartilage 
 
 
 
 
Cartilage 
 
 
 
Cartilage 
 
 
 
 
Cartilage 
 
 
 
Cartilage 
 
 
Hydrostatic Dynamic 
 
 
 
 
Hydrostatic Dynamic 
 
 
 
Hydrostatic Static 
 
 
 
 
Hydrostatic Static 
 
 
 
Hydrostatic Static 
Gellan Gum Hydrogel 
 
 
 
 
Degrapol  
 
 
 
None 
 
 
 
 
Collagen sponges 
 
 
 
Agarose gels 
Human nasal 
chondrocytes 
 
 
 
Bovine 
Chondrocytes 
 
 
Bovine chondrocytes 
 
 
 
 
Bovine chondrocytes 
 
 
 
Human chondrocytes 
Enhanced cartilage 
formation of human nasal 
chondrocytes. 
 
 
Enhanced differentiation on 
3D scaffold. 
 
 
37% decrease in GAG 
synthesis, decreased 
aggrecan mRNA levels.  
 
 
Greater GAG production at 
5 and 15 days of culture.  
 
 
Enhanced aggrecan and 
collagen II mRNA 
expression in chondrocytes  
 
 
Mygind et al 
 
 
 
 
Yu et al  
 
 
Song et al  
 
2007 
 
 
 
 
2004 
 
 
1999 
 
Bone  
 
 
 
 
Bone  
 
 
Bone  
 
Shear Force, Spinner Flask 
 
 
 
 
Shear Force, Rotating vessel 
 
 
Shear Force, Rotating vessel 
 
Coralline hydroxyapatite 
 
 
 
 
PLGA 
 
 
None 
 
Human MSCs 
 
 
 
 
Human  MSCs 
 
 
Rat osteoblast 
 
Enhance osteoblastic 
markers – alkaline 
phosphastase and 
osteocalcin  
 
Enhance osteoblast cell 
phenotype.  
 
Produce greater bone 
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Grayson et al  
 
 
 
2008 
 
 
 
Bone  
 
 
 
 
 
 
 
Perfusion 
 
 
 
 
Decellularized bovine 
trabecular bone 
 
 
 
 
Human  MSCs 
 
formation in bioreactors 
than static controls.  
 
Increased flow rate 
increased mineralised 
matrix formation by 
osteoblast 
 
Chen et al 
 
 
 
 
 
Song et al 
2013 
 
 
 
 
 
2012 
 
Vascular tissue  
 
 
 
 
 
Vascular tissue 
 
An integrated bioreactor 
that mimic the physiological 
pulsatile stimuli  
 
 
 
1). A computer-controlled 
integrated vascular 
bioreactor system.   
 
2). Consists of two 
separated circulation loop: 
The incuating loop and the 
medium-replenishing loop 
3D PGA scaffold  
 
 
 
 
 
Decellularized rabbit 
aorta tissue 
 
ASCs  
 
 
 
 
 
Rat aortic ECs and SMCs 
 
An elastic small diameter 
vessel with certain 
functional and mechanical 
properties similar to natural 
arteries 
 
Higher cell proliferation rate 
than in normal bioreactor 
systems. And a successful 
small-diameter vascular 
constructs harvest in end 
point. 
Stefan et al 2012  Stents 
 
 
 
 
 
 
 
1). Single loop system: 
Culture medium circuit. 
 
2). ECs or EPCs are often 
added into the circling 
culture medium to test the 
cell capturing property of 
the stent 
BioStent (a nitinol stent 
covered with fibrin gel) 
ECs 
 
 
 
 
 
 
 
Cell growth and generation 
of ECMs 
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Genoveva et 
al 
2012 Heart Valves 1). Once direction flow 
circuit 
 
2). Pulsatile flow model 
PU scaffolds Human vascular ECs and 
fibroblasts 
SEM results showed a high 
density of adherent cells on 
the surface valves from both 
groups 
Li et al 
 
 
 
 
 
 
Mitchell et al 
 
 
 
 
 
 
 
 
Prenosil et al 
2011 
 
 
 
 
 
 
2009 
 
 
 
 
 
 
 
 
1999 
Skin 
 
 
 
 
 
 
Skin 
 
 
 
 
 
 
 
 
Skin 
A Rotary Bioreactor: 
Rotating Cell Culture 
System mimicking 
microgravity condition 
 
 
 
The Skin “expander”: 
1). Conventional incubator 
 
2). Programmed linear 
motor-drive device: 
Uniaxially expand fix tissue 
or seeded scaffold in a slow 
and gradual manner 
 
The Kerator: 
1). Has a specific liquid and 
gas exchange surface 
 
2). “Smart” computer-
controlled system: Multiple 
monitoring and feedback 
controlling, Automatically 
changing culturing medium 
Collagen type IV coated 
Cytodex 3 (a micro-
carrier) 
 
 
 
 
None 
 
 
 
 
 
 
 
 
FEP film 
Human EpSCs 
 
 
 
 
 
 
Human foreskin 
 
 
 
 
 
 
 
 
Keratinocytes 
 
Show promotion of 
proliferation and inhibition 
of differentiation in 3D cell 
culture. A 3D epidermis 
tissue harvest in end point. 
 
 
A greater in surface area 
while maintenance of cell 
viability and proliferative 
potential, and the integrity 
of dermal structure. 
 
 
 
 
An autologous wound 
dressing 
Tao et al 2008 Nerve Conduit 1). Aligned microfiber 
inserted into the lumen of 
silicone tubes as conduits 
Acrylic Acid Plasma 
Polymerized Viscose 
Rayon Fiber and  
Schwann cells Fluorescence microscopy 
examination after culture 
showed cellular adhesion 
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2). The conduit can provide 
a locally enriched 
environment of growth 
factors and prevent the 
infiltration of fibroblast and 
inflammatory cells 
 
3). Combined  the above 
conduit approach with 
Schwann cell delivery and a 
conduit filling material 
Polystyrene Microfiber 
as Scaffolds 
 
and alignment on the 
longitudinal axis. 
 
